Introduction
Diffuse Large B-Cell Lymphoma (DLBCL) is a biologically diverse hematologic malignancy. Computational analysis aids in subtype classification, prognostic score development, and biomarker discovery. Explore expert-level abstracts and tools focused on DLBCL profiling and personalized therapy strategies.
